Amiodarone triggers induction of apoptosis in cutaneous leishmaniasis agents

Somayeh Bahrami1, Shahram Khademvatan2, Mohammad Hossein Razi Jalali1

  • 1a Faculty of Veterinary Medicine, Department of Parasitology , Shahid Chamran University of Ahvaz , Ahvaz , Iran.

Insights

Amiodarone (AMD) shows cytotoxic effects against Leishmania parasites causing leishmaniasis. This drug induces programmed cell death, offering potential for new cutaneous leishmaniasis treatments.

Area of Science:

  • Parasitology
  • Pharmacology
  • Cell Biology

Background:

  • Leishmaniasis is a significant global public health concern caused by Leishmania parasites.
  • Current treatments for leishmaniasis have limitations, necessitating the search for novel therapeutic agents.

Purpose of the Study:

  • To evaluate the cytotoxic impact of amiodarone (AMD) on Leishmania tropica and Leishmania major promastigotes.
  • To investigate the mechanisms of programmed cell death induced by AMD in these parasites.

Main Methods:

  • Colorimetric MTT assay to determine parasite viability and calculate 50% inhibitory concentration (IC50).
  • Annexin-V FLUOS staining and fluorescence-activated cell sorting (FACS) analysis to assess apoptosis.
  • Agarose gel electrophoresis for qualitative analysis of genomic DNA fragmentation.
  • Light microscopy for observing morphological changes in promastigotes.

Main Results:

  • Amiodarone exhibited inhibitory effects with IC50 values of 55 μM for L. tropica and 81 μM for L. major after 48 hours.
  • AMD treatment induced features characteristic of apoptosis in both Leishmania strains.
  • Observed apoptotic features included phosphatidylserine externalization, DNA laddering, and cell shrinkage.

Conclusions:

  • Amiodarone demonstrates significant cytotoxic activity against Leishmania tropica and Leishmania major.
  • The mechanism of AMD-induced cell death involves apoptosis in these parasitic agents.
  • These findings suggest amiodarone as a potential candidate for developing new therapies against cutaneous leishmaniasis.